Drugs for Febrile Infection-Related Epilepsy Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 103)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Glycerol |
Approved, Investigational |
Phase 4 |
|
56-81-5 |
753 |
Synonyms:
(2,5-Dihydroxyphenyl)-acetate
(2,5-Dihydroxyphenyl)-acetic acid
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
1,2,3-propanetriol
1,2,3-Propanetriol
1,2,3-trihydroxypropane
1,2,3-Trihydroxypropane
2-(3,6-DIHYDROXYPHENYL)acetate
2-(3,6-DIHYDROXYPHENYL)acetIC ACID
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2,5-Dihydroxy-alpha-toluate
2,5-Dihydroxy-alpha-toluic acid
2,5-Dihydroxy-a-toluate
2,5-Dihydroxy-a-toluic acid
2,5-Dihydroxy-benzeneacetate
2,5-Dihydroxy-benzeneacetic acid
2,5-Dihydroxyphenylacetate
2,5-Dihydroxyphenylacetic acid
Acid, homogentisic
Alcapton
Allomaleate
Allomaleic acid
alpha-delta-Glucopyranuronic acid
alpha-delta-Glucuronic acid
alpha-D-Glucopyranuronic acid
alpha-D-Glucuronic acid
Ammonium fumarate
Boletate
Boletic acid
Bulbold
Concentrated glycerin
Cristal
D-(+)-Glucuronate
D-(+)-Glucuronic acid
delta-(+)-Glucuronate
delta-(+)-Glucuronic acid
delta-Glucuronate
D-Glucuronate
e 422
e297
Emery 916
FC 33
Fumarate
Fumarsaeure
Furamag
GCU
GlcAa
|
GlcAalpha
Glucosiduronate
Glucosiduronic acid
Glucuronate
Glucuronic acid
Glyceol opthalgan
Glycerin
Glycerin, anhydrous
Glycerin, concentrated
Glycerin,anhydrous
Glycerine
glycérine
Glycerinum
Glyceritol
Glycerol
glycérol
Glycerolum
Glycyl alcohol
Glyrol
Glysanin
Glyzerin
Gro
Homogentisate
Homogentisate acid
Homogentisinate
Homogentisinic acid
IFP
Incorporation factor
Lichenate
Lichenic acid
Mackstat H 66
Mafusol
Magnesium fumarate
Melanic acid
Monoctanoin component D
Oelsuess
Ölsüß
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Sodium fumarate
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
Trihydroxypropane
Tryhydroxypropane
|
|
2 |
|
Aspirin |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoate
2-(ACETYLOXY)benzoIC ACID
2349-94-2
26914-13-6
2-Acetoxybenzenecarboxylate
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. empirin
A.S.A. Empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
acide 2-(acétyloxy)benzoïque
Acide acetylsalicylique
Acide acétylsalicylique
Acido acetilsalicilico
ácido acetilsalicílico
Acido O-acetil-benzoico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
AI3-02956
AIN
AKOS000118884
Aloxiprimum
ASA
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspirdrops
aspirin
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina
Aspirina 03
Aspirine
Aspir-Mox
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bialpirina
Bialpirinia
BIDD:GT0118
Bi-prin
BRN 0779271
Bufferin
C01405
Caprin
Cardioaspirin
Cardioaspirina
CCRIS 3243
Cemirit
CHEBI:15365
CHEMBL25
CID2244
Claradin
Clariprin
cMAP_000006
Colfarit
component of Midol
component of Synirin
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
Durlaza
Easprin
Easprin (TN)
ECM
Ecolen
Ecotrin
EINECS 200-064-1
Empirin
|
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EU-0100038
Extren
Globentyl
Globoid
Helicon
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
I14-7505
IDI1_000555
Idragin
Istopirin
Kapsazal
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
Levius
Lopac0_000038
Lopac-A-5376
LS-143
Magnecyl
Measurin
Medisyl
Micristin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
nchem.859-comp6
NCI60_002222
Neuronika
NINDS_000555
Novid
NSC 27223
NSC27223
NSC406186
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-accetylsalicylic acid
O-Acetoxybenzoate
o-acetoxybenzoic acid
o-Acetoxybenzoic acid
O-Acetoxybenzoic acid
O-Acetylsalicylate
O-acetylsalicylic acid
O-Acetylsalicylic acid
o-carboxyphenyl acetate
o-Carboxyphenyl acetate
O-Carboxyphenyl acetate
O-Carboxyphenyl acetic acid
Persistin
Pharmacin
Pirseal
PL-2200
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
Salacetin
Salcetogen
Saletin
Salicylate acetate
Salicylic acid acetate
Salicylic acid acetic acid
Salicylic acid, acetate
Salospir
SMR000059138
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
SP 189
SPBio_001838
Spectrum_001245
SPECTRUM1500130
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
ST075414
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII=R16CO5Y76E
UNII-R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
Xaxa
XAXA
Yasta
Zorprin
ZORprin
|
|
3 |
|
Naloxone |
Approved, Vet_approved |
Phase 4 |
|
465-65-6 |
5284596 |
Synonyms:
(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one
(−)-naloxone
(-)-Naloxone
(5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one
12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone
12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one
17-Allyl-3,14-dihydroxy-4,5a-epoxymorphinan-6-one
17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one
17-Allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one
17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one
1-N-Allyl-14-hydroxynordihydromorphinone
1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one
357-08-4 (hydrochloride)
465-65-6
Abello brand OF naloxone hydrochloride
Abello, naloxone
BIDD:GT0110
Boots brand OF naloxone hydrochloride
BPBio1_000136
BRD-K67511046-003-03-7
Bristol myers squibb brand OF naloxone hydrochloride
Bristol-myers squibb brand OF naloxone hydrochloride
BRN 1089071
BSPBio_000122
C07252
CHEBI:7459
CHEMBL80
CID5284596
Curamed brand OF naloxone hydrochloride
Curamed, naloxon
D08249
DB01183
DBL Naloxone
DBL Naloxone (TN)
Dihydride, naloxone hydrochloride
EINECS 207-365-7
EN 1530 base
EN 1530 Base
endo Brand OF naloxone hydrochloride
HMS2090F20
HSDB 3279
Hydrobromide, naloxone
Hydrochloride dihydride, naloxone
Hydrochloride, naloxone
Lamepro brand OF naloxone hydrochloride
l-N-Allyl-14-hydroxynordihydromorphinone
l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
l-Naloxone
L-Naloxone
|
LS-187184
LS-92141
MolPort-002-536-640
Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)
MRZ 2593 BR
MRZ 2593BR
MRZ 2593-BR
N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon
n-Allylnoroxymorphone
N-Allylnoroxymorphone
N-Allyl-noroxymorphone
Nalone
Nalossone
Nalossone [Dcit]
Nalossone [DCIT]
Naloxon curamed
Naloxon ratiopharm
Naloxona
Naloxona [INN-Spanish]
naloxone
Naloxone
Naloxone (INN)
Naloxone [INN:BAN]
Naloxone abello
Naloxone HCl
Naloxone hydrobromide
Naloxone hydrochloride
Naloxone hydrochloride dihydride
Naloxone hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer
Naloxonratiopharm
Naloxon-ratiopharm
Naloxonum
Naloxonum [INN-Latin]
Narcan
Narcanti
Narcon
NCGC00024674-02
NSC 70413
NSC70413
PDSP2_001520
Prestwick0_000111
Prestwick1_000111
Prestwick2_000111
Prestwick3_000111
Ratiopharm brand OF naloxone hydrochloride
SERB brand OF naloxone hydrochloride
SMP1_000205
SPBio_002061
STOCK1N-69923
UNII-36B82AMQ7N
United drug brand OF naloxone hydrochloride
|
|
4 |
|
Buprenorphine |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
52485-79-7 |
40400 644073 |
Synonyms:
(-)-buprenorphine
(−)-buprenorphine
(-)-Buprenorphine
(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-(methyloxy)-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
[5alpha,7alpha(S)]-17-(Cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol
17-Cyclopropylmethyl-4,5a-epoxy-7a-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
2-(N-Cyclopropylmethyl-4,5a-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6a-yl)-3,3-dimethyl-2-butanol
2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-7alpha-yl)-3,3-dimethyl-2-butanol
2-(N-cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol
2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
21-(Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7a-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7alpha-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
52485-79-7
53152-21-9 (hydrochloride)
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-,
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)- (9CI)
6029-M
AC1L23NL
AC1L9B1M
AC1LD8IH
Buprel
Buprenex
Buprenophine
Buprenorfina
Buprenorfina [INN-Spanish]
buprenorphine
Buprenorphine
Buprenorphine (JAN/INN)
Buprenorphine [INN:BAN]
Buprenorphine grünenthal brand
|
Buprenorphine Hcl
Buprenorphine hydrochloride
Buprenorphinum
Buprenorphinum [INN-Latin]
Buprex
C08007
C29H41NO4
CHEBI:3216
CHEMBL1201894
CHEMBL47085
CID40400
CID441363
CID5311033
CID6321408
CID644073
D07132
DB00921
DEA No. 9064
EINECS 257-950-6
Essex brand OF buprenorphine hydrochloride
Grünenthal brand OF buprenorphine
Grünenthal brand OF buprenorphine hydrochloride
Hydrochloride, buprenorphine
Key brand OF buprenorphine hydrochloride
LS-67682
MolPort-004-285-844
PDSP2_000111
Prefin
Probuphine
Reckitt and colman brand 1 OF buprenorphine hydrochloride
Reckitt and colman brand 2 OF buprenorphine hydrochloride
Reckitt benckiser brand OF buprenorphine hydrochloride
Reckitt brand OF buprenorphine hydrochloride
RX 6029 m
RX 6029M
RX-6029-m
RX-6029-M
Schering plough brand OF buprenorphine hydrochloride
Schering-plough brand OF buprenorphine hydrochloride
Subutex
Temgesic
Temgésic
Temgesic (TN)
UNII-40D3SCR4GZ
|
|
5 |
|
Insulin, Globin Zinc |
|
Phase 4 |
|
|
|
6 |
|
Soy Bean |
|
Phase 4 |
|
|
|
7 |
|
insulin |
|
Phase 4 |
|
|
|
8 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
9 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
10 |
|
Fibrinolytic Agents |
|
Phase 4 |
|
|
|
11 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
12 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
13 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
14 |
|
Platelet Aggregation Inhibitors |
|
Phase 4 |
|
|
|
15 |
|
Antipyretics |
|
Phase 4 |
|
|
|
16 |
|
Narcotics |
|
Phase 4 |
|
|
|
17 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
18 |
|
Narcotic Antagonists |
|
Phase 4 |
|
|
|
19 |
|
Buprenorphine, Naloxone Drug Combination |
|
Phase 4 |
|
|
|
20 |
|
Proton Pump Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
21 |
|
Tissue Plasminogen Activator |
|
Phase 2, Phase 3 |
|
|
|
22 |
|
Levoleucovorin |
Approved, Investigational |
Phase 2 |
|
68538-85-2 |
149436 |
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-Formyltetrahydrofolate
(6S)-5-formyltetrahydrofolic acid
(6S)-5-Formyltetrahydrofolic acid
(6S)-Folinate
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
6 S Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
ácido levofolínico
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid SF
Folinic acid-SF
Fusilev
Kunyrin
Leucoverin
|
Leucovorin
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leukovorin
Leukovorum
Levo leucovorin
Levofolene
Levofolinate
Levofolinic acid
Levoleucovorin
Levo-leucovorin
L-Folinate
L-Folinic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
23 |
|
leucovorin |
Approved |
Phase 2 |
|
58-05-9 |
6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-formyltetrahydrofolate
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-formylTHF
Acide folinique
Acido folinico
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
|
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
L-leucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolic acid
Wellcovorin
|
|
24 |
|
Panitumumab |
Approved, Investigational |
Phase 2 |
|
339177-26-3 |
50070211 |
Synonyms:
339177-26-3
ABX-EGF
ABX-EGF MAb
ABX-EGF Monoclonal Antibody
Clone E7.6.3
D05350
panitumumab
|
Panitumumab
Panitumumab (genetical recombination)
Panitumumab (genetical recombination) (JAN)
Panitumumab (USAN/INN)
Vectibix
Vectibix (TN)
|
|
25 |
|
Fluorouracil |
Approved |
Phase 2 |
|
51-21-8 |
3385 |
Synonyms:
1004-03-1
1-fluoro-1h-pyrimidine-2,4-dione
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 Fluorouracil
5 Fluorouracil biosyn
5 FU lederle
5 FU Lederle
5 FU medac
5 HU hexal
5 HU Hexal
51-21-8
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-fluoropyrimidine-2,4(1H,3H)-dione
5-Fluoropyrimidine-2,4-dione
5-fluorouracil
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5FU
5-FU
5-FU (TN)
5-FU lederle
5-FU Lederle
5-FU medac
5-HU hexal
5-HU Hexal
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
AI3-25297
AKOS000119162
AKOS003237897
Allergan brand OF fluorouracil
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
biosyn Brand of Fluorouracil
Biosyn brand OF fluorouracil
BSPBio_002048
C07649
C4H3FN2O2
Carac
Carac (TN)
Carzonal
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
Cinco FU
CPD000038082
CPD0-1327
CSP Brand of Fluorouracil
CSP Brand OF fluorouracil
Cytosafe
D005472
D00584
Dakota brand OF fluorouracil
Dakota Brand of Fluorouracil
Dakota, fluorouracile
Dakota, Fluorouracile
DB00544
Dermatech brand OF fluorouracil
Dermatech Brand of Fluorouracil
Dermik brand OF fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
EINECS 200-085-6
EU-0100536
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
Ferrer brand OF fluorouracil
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro uracile icn
Fluoro Uracile ICN
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
fluorouracil
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil [USAN:INN:BAN:JAN]
Fluorouracil gry
Fluorouracil GRY
Fluorouracil mononitrate
Fluorouracil Mononitrate
Fluorouracil monopotassium salt
Fluorouracil Monopotassium Salt
Fluorouracil monosodium salt
Fluorouracil Monosodium Salt
Fluorouracil potassium salt
Fluorouracil Potassium Salt
Fluorouracil teva brand
Fluorouracil Teva Brand
Fluorouracile
Fluoro-uracile
|
Fluorouracile [DCIT]
Fluorouracile dakota
Fluorouracile Dakota
Fluoro-uracile icn
Fluoro-Uracile ICN
Fluorouracil-gry
Fluorouracil-GRY
Fluorouracilo
Fluoro-uracilo
Fluorouracilo [INN-Spanish]
Fluorouracilo ferrer far
Fluorouracilo Ferrer Far
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
FT-0082524
Ftoruracil
FU
Gry brand OF fluorouracil
Gry Brand of Fluorouracil
Haemato brand OF fluorouracil
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal brand OF fluorouracil
Hexal Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
I07-0022
ICN brand OF fluorouracil
ICN Brand of Fluorouracil
IDI1_000054
IN1335
inhibits thymilidate synthetase
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
Lopac0_000536
Lopac-F-6627
LS-153
medac Brand of Fluorouracil
Medac brand OF fluorouracil
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
nchembio.90-comp3
nchembio809-comp6
NCI60_001652
Neocorp brand OF fluorouracil
Neocorp Brand of Fluorouracil
Neofluor
NINDS_000054
NSC 19893
NSC19893
NSC-19893
Onkofluor
Onkoworks brand OF fluorouracil
Onkoworks Brand of Fluorouracil
Pharmachemie brand OF fluorouracil monosodium salt
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
ribosepharm Brand of Fluorouracil
Ribosepharm brand OF fluorouracil
Riemser brand OF fluorouracil
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche brand OF fluorouracil
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
Spectrum_000841
SPECTRUM1500305
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
STK297802
T5233394
tetratogen
Teva brand OF fluorouracil
Teva Brand of Fluorouracil
Timazin
TL8006093
U 8953
U-8953
Ulup
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
WLN: T6MVMVJ EF
ZINC00897110
|
|
26 |
|
Irinotecan |
Approved, Investigational |
Phase 2 |
|
97682-44-5, 100286-90-6 |
60838 |
Synonyms:
(+)-Irinotecan
(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE
(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate
1u65
7 Ethyl 10 hydroxycamptothecin
7-Ethyl-10-hydroxycamptothecin
97682-44-5
AC1L1U0Z
AC1Q6PGI
AC-7469
Bio-0054
Biotecan
Biotecan (TN)
BRD-K08547377-003-02-4
BSPBio_002346
C16641
C33H38N4O6
Campothecin-11
Campto
Camptosar
Camptosar, Campto, CPT-11, Irinotecan
Camptothecin 11
Camptothecin-11
CHEBI:105985
CHEMBL481
CID60838
CP0
CPT 11
CPT11
CPT-11
D08086
|
DB00762
FT-0083650
HSDB 7607
Irinophore C
irinotecan
Irinotecan
Irinotecan (INN)
Irinotecan [INN:BAN]
Irinotecan Hcl
Irinotecan hydrochloride
Irinotecan Hydrochloride
Irinotecan hydrochloride trihydrate
Irinotecan Hydrochloride Trihydrate
IRINOTECAN HYDROCHLORIDE Trihydrate
Irinotecan lactone
Irinotecan mylan
IRINOTECAN, CPT-11
Irinotecanum
Irinotecanum [INN-Latin]
Irrinotecan
LS-44589
NCI60_005051
NK012 Compound
NSC728073
S1198_Selleck
sn 38
sn-38
sn38 CPD
TL8006026
UNII-7673326042
|
|
27 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 2 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
ácido fólico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
|
Folipac
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
28 |
|
Skullcap |
|
Phase 1, Phase 2 |
|
|
|
29 |
|
Protective Agents |
|
Phase 2 |
|
|
|
30 |
|
Nutrients |
|
Phase 2 |
|
|
|
31 |
|
Vitamin B Complex |
|
Phase 2 |
|
|
|
32 |
|
Micronutrients |
|
Phase 2 |
|
|
|
33 |
|
Hematinics |
|
Phase 2 |
|
|
|
34 |
|
Trace Elements |
|
Phase 2 |
|
|
|
35 |
|
Antineoplastic Agents, Immunological |
|
Phase 2 |
|
|
|
36 |
|
Vitamin B9 |
|
Phase 2 |
|
|
|
37 |
|
Vitamins |
|
Phase 2 |
|
|
|
38 |
|
Folate |
|
Phase 2 |
|
|
|
39 |
|
topoisomerase I inhibitors |
|
Phase 2 |
|
|
|
40 |
|
Antidotes |
|
Phase 2 |
|
|
|
41 |
|
Alprostadil |
Approved, Investigational |
|
|
745-65-3 |
149351 5280723 |
Synonyms:
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(-)-Prostaglandin e1
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oate
(11α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oic acid
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoic acid
(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid (acd/name 4.0)
119314-69-1
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoate
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoic acid
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoate
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoate
11α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
745-65-3
82474_FLUKA
A0593_SIAL
AB00514004
Abbott brand OF alprostadil
AC1NQXHQ
AC-6095
Alista
Allphar brand OF alprostadil
alprostadil
Alprostadil
Alprostadil (JP15/USP/INN)
Alprostadil prostoglandin e1
Alprostadil Prostoglandin E1
Alprostadil(usan)
Alprostadilum
Alprox-TD
Astra brand OF alprostadil
AstraZeneca brand OF alprostadil
Befar
Befar (TN)
BIDD:GT0747
BML1-F06
BPBio1_001293
BRD-K52459643-001-06-0
BSPBio_001175
BSPBio_001488
C04741
Caverject
Caverject impulse
CHEBI:15544
CHEMBL495
CID5280723
CPD000112594
D00180
|
DB00770
Edex
FemLife
Femprox
HEI-507
HMS1361K10
HMS1571K17
HMS1791K10
HMS1989K10
HMS2052L11
HMS2090L08
Hoyer brand OF alprostadil
IDI1_033958
Janssen brand OF alprostadil
Lipo pge1
Lipo-pge1
LMFA03010134
l-Prostaglandin E1
L-Prostaglandin e1
Minprog
MLS000758964
MLS001424250
MolPort-003-939-183
MR 256
MR-256
Muse
NCGC00025234-02
NCGC00025234-03
NCGC00025234-04
NCGC00025234-05
P5515_SIAL
P5515_SIGMA
P7527_SIGMA
P8908_SIGMA
Paladin brand OF alprostadil
PGE1
PGE-1
PGE1 Oligomer
PGE1alpha
Pharmacia brand 1 OF alprostadil
Pharmacia brand 2 OF alprostadil
Prestwick2_001018
Prestwick3_001018
Prink
Prink (TN)
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer
Prostaglandin e1
Prostaglandin E1
Prostaglandin e1alpha
Prostavasin
Prostin VR
Prostin VR pediatric
Prostin VR Pediatric
Prostin VR pediatric (TN)
Prostine VR
RayVa
SAM001246840
SAM001246845
SAM001247093
Schwarz brand OF alprostadil
Schwarz pharma brand OF alprostadil
SMP2_000271
SMR000112594
ST50826271
Sugiran
Topiglan
U-10136
U-10136alprostadil
U-10136prostin
Vasaprostan
Viridal
Vitaros
Vivus brand OF alprostadil
|
|
42 |
|
Verapamil |
Approved |
|
|
52-53-9 |
2520 |
Synonyms:
(+-)-Verapamil
(+/-)-VERAPAMIL
(1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile
2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
52-53-9
56949-77-0
AB00053495
AC-16016
AC1L1DV5
Akilen
alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
Anpec
Apo-verap
Apo-Verap
Arpamyl
Arpamyl LP
Berkatens
Bio-0754
Bio1_000425
Bio1_000914
Bio1_001403
Bio2_000233
Bio2_000713
BPBio1_000268
BRD-A09533288-001-02-7
BRD-A09533288-003-05-6
BSPBio_000242
BSPBio_001513
BSPBio_002358
C07188
C27H38N2O4
Calan
Calan SR
Calaptin
Calaptin 240 SR
Calcan
Cardiabeltin
Cardiagutt
Cardibeltin
Cardioprotect
Caveril
CCRIS 6749
CHEBI:9948
CHEMBL6966
CID2520
Civicor
Civicor retard
cMAP_000023
Coraver
Cordilox
Cordilox SR
Corpamil
Covera-HS
CP-16533-1
CP-16533-1Calan
CP-165331Verapamil
D02356
D-365
D-365Iproveratril
DB00661
delta-365
Dexverapamil
Dignover
Dilacoran
Dilacoran hta
DivK1c_000399
Drosteakard
Durasoptin
EINECS 200-145-1
EINECS 260-462-6
Elthon
Falicard
Finoptin
Flamon
FT-0080127
Geangin
Harteze
Hexasoptin
Hexasoptin retard
HMS1791L15
HMS1989L15
HMS2089H17
Hormitol
Hydrochloride, verapamil
I06-0063
IDI1_000399
IDI1_033983
Ikacor
Ikapress
Inselon
Iproveratril
Isoptimo
Isoptin
Isoptin retard
Isoptin SR
Isoptine
Isoptino
Isotopin
Izoptin
Jenapamil
KBio1_000399
KBio2_000233
KBio2_002343
KBio2_002801
KBio2_004911
KBio2_005369
KBio2_007479
|
KBio3_000465
KBio3_000466
KBio3_002823
KBioGR_000233
KBioGR_001372
KBioGR_002343
KBioSS_000233
KBioSS_002346
L001330
Lekoptin
Lodixal
Lopac0_001237
LS-174
Magotiron
Manidon
Manidon retard
MolPort-000-721-258
NCGC00016083-14
NCGC00024710-04
NCGC00024710-05
NCGC00024710-06
NCGC00024710-07
NCGC00024710-08
NCGC00024710-09
nchembio.368-comp2
nchembio.79-comp5
NCI60_020143
NINDS_000399
Novapamyl LP
Novo-veramil
Novo-Veramil
NSC272366
Nu-verap
NU-Verap
Ormil
Praecicor
Prestwick0_000141
Prestwick1_000141
Prestwick2_000141
Prestwick3_000141
Quasar
Rapam
Robatelan
Sandoz brand OF verapamil
Securon
SPBio_001820
SPBio_002181
Spectrum2_001740
Spectrum4_000906
Spectrum5_001786
STK538085
Tarka
UNII-CJ0O37KU29
Univer
Univex
Vasolan
Vasomil
Vasopten
Verabeta
Veracaps SR
Veracim
Veracor
Verahexal
Veraloc
Veramex
Veramil
Verapamil
VERAPAMIL
Vérapamil
Verapamil (USAN/INN)
Verapamil [Usan:Ban:Inn]
Verapamil [USAN:BAN:INN]
Verapamil [USAN:INN:BAN]
Verapamil acis
Verapamil al
Verapamil atid
Verapamil basics
Verapamil ebewe
Verapamil HCl
Verapamil HCL
Verapamil henning
Verapamil hydrochloride
Verapamil injection
Verapamil MSD
Verapamil NM
Verapamil NM pharma
Verapamil nordic
Verapamil PB
Verapamil riker
Verapamil sandoz brand
Verapamil SR
Verapamil verla
Verapamil-abz
Verapamilo
Verapamilo [INN-Spanish]
Verapamilum
Verapamilum [INN-Latin]
Verapin
Verapress 240 SR
Veraptin
Verasal
Vera-sanorania
Verasifar
Veratensin
Verdilac
Verelan
Verelan PM
Verelan SR
Verexamil
Veroptinstada
Verpamil
Vetrimil
Vortac
|
|
43 |
|
Acetylcholine |
Approved, Investigational |
|
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
|
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
44 |
|
Nitroprusside |
Approved, Investigational |
|
|
15078-28-1 |
11963622 |
Synonyms:
[Fe(CN)5(no)](2-)
13755-38-9 (di-hydrochloride salt, diH20)
14402-89-2 (di-hydrochloride salt)
15078-28-1
C07269
CHEMBL74115
CID11953891
Disodium nitroprusside dihydrate
LS-187044
Nipride
|
Nitroferricyanide
Nitropress
Nitroprusside
Pentacyanidonitrosylferrate(2-)
Pentacyanidonitrosylferric acid(2-)
Sodium nitroferricyanide dihydrate
Sodium Nitroprusside
Sodium nitroprusside dihydrate
Sodium nitroprusside extra pure
UNII-169D1260KM
|
|
45 |
|
Memantine |
Approved, Investigational |
|
|
19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
19982-08-2
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-dimethyladamantan-1-amine
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
Axura
BBL000737
Biomol-NT_000209
BPBio1_001117
BPBio1_001270
BSPBio_001015
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DivK1c_000068
DMAA
Ebixa
EU-0053634
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
KBio2_006223
|
KBio3_001926
KBioGR_001543
KBioSS_001087
Lopac0_000861
LS-157051
Lundbeck brand OF memantine hydrochloride
Memantin
Memantina
Memantina [INN-Spanish]
memantine
Memantine
Memantine (INN)
Memantine [INN:BAN]
Memantine [INN]
Memantine HCL
Memantine hydrochloride
Memantine Hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
MolPort-002-041-858
Namenda
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
Spectrum_000607
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
ST057652
STK520682
UNII-W8O17SJF3T
ZERO/006024
|
|
46 |
|
Riluzole |
Approved, Investigational |
|
|
1744-22-5 |
5070 |
Synonyms:
1744-22-5
2 Amino 6 trifluoromethoxybenzothiazole
2-amino-6-(trifluoromethoxy)-1,3-benzothiazole
2-amino-6-(trifluoromethoxy)benzo[d]thiazole
2-Amino-6-(trifluoromethoxy)benzothiazole
2-Amino-6-(trifluoromethoxy)-benzothiazole
2-amino-6-(trifluoromethoxyl)benzothiazole
2-Amino-6-trifluoro- methoxybenzothiazole
2-amino-6-trifluoromethoxybenzothiazole
2-Amino-6-trifluoromethoxybenzothiazole
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
6-(trifluoromethoxy)benzo[d]thiazol-2-amine
6-Trifluoromethoxy-benzothiazol-2-ylamine
6-trifluoromethoxybenzothiazole-2-yl-amine
AC1L1JJL
AC1Q530H
AC-730
AKOS000265071
ALBB-006046
Amino-2 trifluoromethoxy-6 benzothiazole
Amino-2 trifluoromethoxy-6 benzothiazole [French]
Aventis behring brand OF riluzole
Aventis brand OF riluzole
BB_SC-4839
BF-37
BIDD:GT0055
Bio1_000416
Bio1_000905
Bio1_001394
Biomol-NT_000245
BPBio1_000037
BPBio1_000837
BRD-K21283037-001-02-5
BRD-K21283037-003-03-9
BSPBio_000033
C07937
C8H5F3N2OS
CHEMBL744
CID5070
D00775
DB00740
EU-0101064
FT-0082997
HMS1773G08
HMS2089O19
HMS2094G07
I01-2084
Impax brand OF riluzole
Lopac0_001064
|
Lopac-R-116
LS-40688
MLS000069369
MolPort-000-151-262
NCGC00015882-01
NCGC00015882-02
NCGC00015882-03
NCGC00015882-07
NCGC00015882-11
NCGC00023141-02
NCGC00023141-04
NCGC00023141-05
NCGC00023141-06
PK-26124
PK-26124, RP-54274, Rilutek, Riluzole
Prestwick0_000167
Prestwick-03A08
Prestwick1_000167
Prestwick2_000167
Prestwick3_000167
R-116
R116_SIGMA
Rhone poulenc rorer brand OF riluzole
Rhone-poulenc rorer brand OF riluzole
Rilutek
Rilutek (TN)
Riluzol
Riluzol [INN-Spanish]
riluzole
Riluzole
Riluzole (JAN/USAN/INN)
Riluzole [USAN:INN]
Riluzole aventis brand
Riluzole HCl
Riluzole impax brand
Riluzolum
Riluzolum [INN-Latin]
RP 54274
RP-54274
S1614_Selleck
SMR000058231
SPBio_000599
SPBio_001954
Spectrum2_000550
STK503686
Tocris-0768
UNII-7LJ087RS6F
ZERO/001785
ZINC00006481
|
|
47 |
|
Dopamine |
Approved |
|
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
Hydroxytyramin
|
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
48 |
|
Isradipine |
Approved, Investigational |
|
|
75695-93-1 |
3784 |
Synonyms:
(+-)-Isradipine
(+/-)-isradipine
(+/-)-Isradipine
2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-(1-methylethyl) ester
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester (9CI)
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester
3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
4-(2,1,3-Benzooxadiazol-4-yl)-2.6-dimethyl-1,4-dihydro-3-isopropyloxycarbonylpyridine-5-carboxylic Acid Methyl Ester
4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methhylethyl ester
4-(4-Benzofurazanyl)-1,4-dihydro-2,-6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
75695-93-1
88977-22-4
AB00514007
AC1L1GPE
AC1Q426L
BPBio1_001323
BRD-A90799790-001-03-3
BSPBio_001201
C19H21N3O5
CHEMBL1648
CHEMBL315436
CID3784
Clivoten
CPD000466320
D00349
D017275
DB00270
Dynacirc
DynaCirc
DynaCirc (TN)
Dynacirc CR
DynaCirc, Prescal, PN-200-110, Clivoten, Esradin, Isradipine
DynaCire
DynaCire CR
Dynacrine
Esradin
HMS1571M03
HMS2051J12
I06-0364
I6658_SIGMA
Icaz
isopropyl 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridinecarboxylate
Isopropyl methyl (+-)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
Isradipin
isradipine
Isradipine
Isradipine (USP/INN)
Isradipine [USAN:INN:BAN]
Isradipine, (+-)-isomer
|
Isradipine, (+-)-Isomer
Isradipine, (R)-isomer
Isradipine, (R)-Isomer
Isradipine, (S)-isomer
Isradipine, (S)-Isomer
Isradipino
Isradipino [Spanish]
Isradipinum
Isradipinum [Latin]
Isrodipine
KBio2_000698
KBio2_003266
KBio2_005834
KBioSS_000698
Lomir
LS-131190
LS-177211
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
MLS000759425
MLS001424076
MLS002154106
MolPort-003-848-292
NCGC00025341-02
NCGC00025341-03
O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
PN 200
PN 200-110
PN 205 033
PN 205 034
PN 205033
PN 205-033
PN 205034
PN 205-034
PN-200110
PN-200-110
PN205033
PN-205-033
PN205034
PN-205-034
Prescal
Prestwick0_001021
Prestwick1_001021
Prestwick2_001021
Prestwick3_001021
Rebriden
S1662_Selleck
SAM001246584
SMR000466320
SPBio_003062
Spectrum_000218
UNII-YO1UK1S598
|
|
49 |
|
Lidocaine |
Approved, Vet_approved |
|
|
137-58-6 |
3676 |
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-Diethylamino-2,6-dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
Leostesin
Lida-Mantle
Lidocaina
|
Lidocaína
Lidocaina [INN-Spanish]
lidocaine
Lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
Α-diethylamino-2,6-dimethylacetanilide
|
|
50 |
|
Caffeine |
Approved |
|
|
58-08-2 |
2519 |
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-trimethylpurine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1,3,7-Trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
137X
1gfz
1l5q
1l7x
1-methyltheobromine
1-Methyltheobromine
1-Methyl-theobromine
27602_FLUKA
2a3b
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-dihydro-1,3,7-trimethyl-1H-purine
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
5-26-13-00558 (Beilstein)
58-08-2
71701-02-5
75035_FLUKA
7-Methyl theophylline
7-methyltheophylline
7-Methyltheophylline
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-pep
Alert-Pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
Berlin-chemie brand OF caffeine
Berlin-Chemie Brand of Caffeine
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
bmse000206
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
Bristol-myers squibb brand OF caffeine
Bristol-Myers Squibb Brand of Caffeine
BRN 0017705
BSPBio_001921
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
Cafamil
Cafcit
Cafecon
Cafeina
Cafeína
cafeine
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
caffeine
Caffeine (natural)
Caffeine (USP)
Caffeine [BAN:JAN]
Caffeine Pure
Caffeine solution
Caffeine, anhydrous
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, synthetic
Caffeine, Synthetic
Caffeinum
caffenium
Caffine
Cafipel
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum purrum
Coffeinum Purrum
component of Cafergot
Compound 65
CU-01000012617-3
D002110
D00528
Darvon Compound
Darvon Compound-65
Dasin
DB00201
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
DHC Plus
DHCplus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
EU-0100228
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
Hycomine Compound
I14-4386
|
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
Lanorinal
Lopac0_000228
Lopac-C-0750
LS-237
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
MEGxp0_001350
Merck dura brand OF caffeine
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MLS001055341
MLS001056714
MLS001066409
MolMap_000054
MolPort-000-730-850
Monohydrate caffeine
Monomethyl derivative of Theophylline
Monomethyl Derivative of Theophylline
Natural Caffeinum
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
NCI-C02733
NCIOpen2_008255
NINDS_000730
Nix Nap
No doz
No Doz
Nodaca
No-Doz
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC 5036
NSC5036
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
Passauer brand OF caffeine
Passauer Brand of Caffeine
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Pep-Back
Percoffedrinol N
Percutafeine
Percutaféine
Phensal
Pierre fabre brand OF caffeine
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick Pep
Quick-pep
QuickPep
Quick-Pep
Refresh'n
Republic drug brand OF caffeine
Republic Drug Brand of Caffeine
Respia
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
Seid brand OF caffeine
Seid Brand of Caffeine
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
Spectrum_001301
SPECTRUM1500155
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Stim
STK177283
Synalgos-Dc
teina
Teina
Teína
Thein
Theine
Theobromine Me
Theobromine ME
Theophylline Me
Theophylline ME
Theophylline, 7-methyl
Thompson brand 1 OF caffeine
Thompson Brand 1 of Caffeine
Thompson brand 2 OF caffeine
Thompson Brand 2 of Caffeine
Tirend
TNP00310
Triad
Tri-Aqua
Ultra Pep-Back
UNII-3G6A5W338E
Vivarin
W222402_ALDRICH
Wake-Up
Wigraine
WLN: T56 BN DN FNVNVJ B1 F1 H1
Xanthine, 1,3,7-trimethyl
ZINC00001084
|
|
Interventional clinical trials:
(show top 50)
(show all 132)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Adjuvant Magnesium Trial (AdMag): Assessment if the Impact of Oral Magnesium on ICD Firing and Quality of Life |
Unknown status |
NCT00282620 |
Phase 4 |
Magnesium L-lactate |
2 |
Assessment of the Implementation of the ResQGARD® Impedance Threshold Device by the San Antonio Fire Department |
Completed |
NCT01780350 |
Phase 4 |
|
3 |
Fat, Inflammation and Insulin Resistance (FIRE-Study) |
Completed |
NCT01054989 |
Phase 4 |
|
4 |
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting |
Completed |
NCT01276691 |
Phase 4 |
81 mg enteric coated aspirin |
5 |
A Randomized Prospective Study of Endoscopy Bipolar Eletrocoagulation and Argon Plasma Coagulation of Chronic Rectal Bleeding From Radiation Telangiectasias |
Completed |
NCT00725244 |
Phase 4 |
|
6 |
Houston Emergency Opioid Engagement System (HEROES) |
Recruiting |
NCT03396276 |
Phase 4 |
Suboxone |
7 |
The BIOPRES Trial; Transrectal BIOpsies of the PRostate: End Versus Side-firing |
Unknown status |
NCT00851292 |
Phase 3 |
|
8 |
Prospective Randomized Study of Cryotherapy Versus Argon Plasma Coagulation Therapy for Treatment Of Watermelon Stomach |
Completed |
NCT00587405 |
Phase 2, Phase 3 |
|
9 |
The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder |
Completed |
NCT03477799 |
Phase 3 |
|
10 |
BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Compared to Standard Management by Emergency Medical Services:The BEST-MSU Study |
Recruiting |
NCT02190500 |
Phase 2, Phase 3 |
|
11 |
Multicenter Study of Non-invasive Repetitive Paraorbital Alternating Current Stimulation of the Brain: Therapy for Aphasy |
Terminated |
NCT01277575 |
Phase 3 |
|
12 |
Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome (Acute Pericoronitis, Minor Recurrent Aphthous Stomatitis and Recurrent Herpes Simplex Labialis) |
Unknown status |
NCT03469232 |
Phase 1, Phase 2 |
Huanglian-Jiedu Decoction |
13 |
Transcranial Direct Current Stimulation in Rehabilitation of Chronic Stroke Patients: Multicenter Clinical Trial |
Unknown status |
NCT02166619 |
Phase 2 |
|
14 |
Parent Training in Child Safety Practices |
Completed |
NCT02934633 |
Phase 2 |
|
15 |
Vibration Therapy Effects on Muscle Firing Patterns |
Completed |
NCT00510328 |
Phase 1, Phase 2 |
|
16 |
Application of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants and Assessment of Its Benefits Compared to Synchronized Intermittent Mandatory Ventilation (SIMV) With Pressure Support (PS) |
Completed |
NCT01389882 |
Phase 2 |
|
17 |
Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions |
Completed |
NCT01418820 |
Phase 2 |
|
18 |
Treating Primary Progressive Aphasia (PPA) and Elucidating Neurodegeneration in the Language Network Using Transcranial Direct Current Stimulation (tDCS) |
Recruiting |
NCT04046991 |
Phase 2 |
|
19 |
FIRE-5 -Study: Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation |
Not yet recruiting |
NCT04034173 |
Phase 2 |
Panitumumab;Irinotecan;Folinic acid;5-FU |
20 |
A Multicenter, Phase II, Open Label Trial to Determine Optimal Imaging Parameters and Assess the Safety of LMI 1195 in Low Risk Patients and Heart Failure Patients With a History of Firing of an Implantable Cardioverter-Defibrillator |
Withdrawn |
NCT01085175 |
Phase 2 |
LMI 1195 |
21 |
Ease-it Spray for the Treatment of Fire Ant Stings |
Completed |
NCT00435552 |
Phase 1 |
|
22 |
Developing, Implementing and Evaluating Intervention Module on Preventing Fire, Burns and Scalds Injury Among Children Ages 7 to 11 Years In Sentul, Kuala Lumpur |
Unknown status |
NCT03618940 |
|
|
23 |
A Worldwide Post-Market Surveillance Registry to Assess the Medigus Ultrasonic Surgical Endostapler (MUSEâ„¢) System for the Treatment of GERD |
Unknown status |
NCT02366169 |
|
|
24 |
Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH |
Unknown status |
NCT02683980 |
|
|
25 |
Effect of Fire Suppression and Emergency Duties on Vascular Function in Firefighters |
Unknown status |
NCT01805063 |
|
|
26 |
Impact of Persistent Conductances on Motor Unit Firing in SCI |
Unknown status |
NCT02136823 |
|
sugar pill;Riluzole;Isradipine;Memantine |
27 |
Keller Fire Rescue Study of Prehospital Ultrasound Use |
Unknown status |
NCT01074112 |
|
|
28 |
Effect of Real-fire Training on Vascular Function |
Unknown status |
NCT01812317 |
|
|
29 |
Dual Dispatch of EMS, Fire Fighters and/or Police in Out-of-hospital Cardiac Arrest Implemented in Nine Counties in Sweden - Can More Lives be Saved by Using This Method? |
Unknown status |
NCT02184468 |
|
|
30 |
Assessing the Impact of the Resilient Minds Program in Fire Departments |
Unknown status |
NCT03401684 |
|
|
31 |
Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial |
Unknown status |
NCT02964533 |
|
|
32 |
Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study |
Unknown status |
NCT02353533 |
|
|
33 |
Endobronchial Ultrasonography With a Guide Sheath Versus Computed Tomography-guided Transthoracic Needle Biopsy in the Diagnosis of Peripheral Pulmonary Lesions |
Unknown status |
NCT02740400 |
|
|
34 |
Improving Nutrition and Health Outcomes in Intibuca, Honduras |
Unknown status |
NCT01303016 |
|
|
35 |
A Randomised Control Trial to Compare the Pneupac VR1 Portable Ventilator and Manual Ven-tilation Via a Mapleson C- Circuit During the Intra-hospital Transfers of Intubated Patients |
Unknown status |
NCT02782871 |
|
|
36 |
Using mHealth Tools to Deliver Integrated Community Case Management (ICCM) to Village Health Team (VHT) Volunteers in Uganda. |
Unknown status |
NCT02971449 |
|
|
37 |
tDCS Guided by Interhemispheric Assimetry Level on Upper Limb Rehabilitation of Post Stroke Patients |
Completed |
NCT03446378 |
|
|
38 |
Worksite Exercise Interventions for Low Back Injury Prevention in Firefighters |
Completed |
NCT02362243 |
|
|
39 |
Effect of Omentectomy on Metabolic Syndrome, Acute Phase Reactants & Inflammatory Mediators in Patients Undergoing LRYGBP: A Randomized Trial |
Completed |
NCT00923260 |
|
|
40 |
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique, in Investigating a Raised Prostatic Specific Antigen (PSA)? |
Completed |
NCT02761135 |
|
|
41 |
FIRE AND ICE Re-Ablations: Retrospective Data Collection on Re-ablations Performed Within the FIRE AND ICE Trial |
Completed |
NCT03314753 |
|
|
42 |
Therapeutic Effects of Acupuncture Plus Fire Needle Versus Acupuncture on Lateral Epicondylitis: A Randomized Case-control Pilot Study |
Completed |
NCT03820856 |
|
|
43 |
Group-based Intervention for Alcohol, Drugs and Aggression Among Club Patrons |
Completed |
NCT03652688 |
|
|
44 |
Is it Possible to Treat Cyanide Poisoning With HBO? |
Completed |
NCT00399100 |
|
|
45 |
Evaluation of Post-Exposure Sauna Treatment of Firefighters - A Pilot Study, Institutional Review Board# 1801201082 |
Completed |
NCT03429348 |
|
|
46 |
The Effectiveness of an On-line Training Program on Hospital Medical Staff to Improve Fire Knowledge |
Completed |
NCT02438150 |
|
|
47 |
Early Auditory Referral in Primary Care (EAR-PC) |
Completed |
NCT03004937 |
|
|
48 |
An EPIC Based BPA to Enhance Quit Line Referral and Use |
Completed |
NCT03229356 |
|
|
49 |
Smoking in the Paris Fire Brigade and Comparison According to the Type of Service (Permanent or On-call) |
Completed |
NCT04566198 |
|
|
50 |
Evaluation of Cardiac Arrest Recognition by Non-physicians Dispatchers in the Paris Fire Brigade Emergency Call Dispatch Center |
Completed |
NCT01992419 |
|
|
|